In another therapeutic approach, an ENO1-binding peptide, when conjugated with chemotherapeutic agents such as doxorubicin or vinorelbine, could exhibit an enhanced antitumor effect in a mouse model of human colorectal cancer (61). The gene discussed is ENO1; the disease is colorectal cancer.